BLBAUPOST GROUP LLC/MA

Institutional investor · Portfolio as of Q3 2019

SEC EDGAR SourceSEC Filings

Top Holdings32 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
LBYKVLBYKVDelisted

LIBERTY GLOBAL PLC

44M$1B11.8%
4 qtrssince 2018-Q4
Increased
66

VIASAT INC

13.7M$1B11.7%$58.03+29.95%
4 qtrssince 2018-Q4
Unchanged
0

FOX CORP - CLASS A

27.3M$861.6M9.8%$33.43-13.22%
3 qtrssince 2019-Q1
Unchanged
0

EBAY INC

16.6M$648.9M7.3%$27.41+25.99%
4 qtrssince 2018-Q4
Decreased
0

CHENIERE ENERGY INC

10.1M$639.4M7.2%$55.26+9.19%
4 qtrssince 2018-Q4
Decreased
0

BRISTOL-MYERS SQUIBB CO

10M$507.1M5.7%$35.64+10.26%
3 qtrssince 2019-Q1
Decreased
0
CBSCBSDelisted

CBS CORP NEW

12M$484.4M5.5%
4 qtrssince 2018-Q4
Increased
73

QORVO INC

5.7M$421.2M4.8%$60.79+20.46%
4 qtrssince 2018-Q4
Decreased
0
??TESLA INCDelisted
Bond
300M$303.5M3.4%
Unchanged
0
CLNYCLNYDelisted
REIT

COLONY CAP INC NEW

49.7M$299.1M3.4%
4 qtrssince 2018-Q4
Unchanged
0

P G & E CORP

24.5M$245M2.8%$21.40-53.28%
4 qtrssince 2018-Q4
Unchanged
0

NEXSTAR MEDIA GROUP INC

2M$204.6M2.3%$72.92+12.68%
4 qtrssince 2018-Q4
Increased
71

UNIVAR INC

9.5M$197.2M2.2%
4 qtrssince 2018-Q4
Unchanged
0
LBYAVLBYAVDelisted

LIBERTY GLOBAL PLC

7.7M$189.5M2.1%
4 qtrssince 2018-Q4
Increased
55

THERAVANCE BIOPHARMA INC

9.3M$181.3M2.1%$23.43-17.03%
4 qtrssince 2018-Q4
Unchanged
0

FOX CORP - CLASS B

5.7M$179.2M2.0%$32.49-11.08%
3 qtrssince 2019-Q1
Unchanged
0

MCKESSON CORP

1.3M$178.5M2.0%$107.16+21.14%
4 qtrssince 2018-Q4
Decreased
0
TBIOTBIODelisted

Telesis Bio, Inc.

17.5M$172.2M2.0%
4 qtrssince 2018-Q4
Increased
78

SYNCHRONY FINANCIAL

5M$170.6M1.9%$19.63+45.85%
4 qtrssince 2018-Q4
Decreased
0
TAKTAK
ADR

TAKEDA PHARMACEUTIC-SP ADR

9.4M$162.3M1.8%$19.07-7.55%
3 qtrssince 2019-Q1
Decreased
0
$8.8B
AUM
32
Positions
Q3 2019
Filing
Rating · 4.5
Quarterly Portfolio Change
+3%Q1'19$11.9B-7%Q2'19$11B-20%Q3'19$8.8B
Activity profile
$ moved · Q3'19
New8%Increased10%Decreased50%Exited31%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 quarters
<1Q9%1-4Q88%1-2Y0%2Y+3%

BAUPOST GROUP LLC/MA manages $8.8B across 32 positions as of Q3 2019. Top holdings: LBYKV (11.8%), VSAT (11.7%), FOXA (9.8%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 4.5/5.0.

Q3 2019 Summary

Added 3 new positions, exited 3, increased 6, trimmed 11. Top move: TBIO (INCREASED, conviction 78). Portfolio: $8.8B across 32 positions.

Top holdings by portfolio weight

Total AUM$9B
LBYKV11.84%
VSAT11.71%
FOXA9.76%
EBAY7.35%
LNG7.24%
BMY5.74%
CBS5.49%
QRVO4.77%
TESLA INC3.44%
CLNY3.39%
Other2.77%

Portfolio allocation by GICS sector

Sectors9
Unknown28.54%
Healthcare17.96%
Technology17.13%
Communication Services14.97%
Energy8.65%
Consumer Cyclical7.63%
Utilities2.88%
Financial Services2.01%
Basic Materials0.23%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Unknown, Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Elite(4.5 / 5.0)
Track Record79
Conviction46
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
3Q
GPCGPCGENUINE PARTS CO
Q4 2025 Q2 2026+1.4M shares-$167.9M
2Q
GOOGGOOGALPHABET INC-CL C
Q1 2026 Q2 2026+284,750 shares-$338.3M
2Q
AMZNAMZNAMAZON.COM INC
Q1 2026 Q2 2026+1.6M shares-$648.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used